US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Wag! Group Co

0.1144

-0.0044-3.70%

Post-market: 0.11810.0037+3.23%19:38 EDT

Volume:521.41K

Turnover:58.65K

Market Cap:5.80M

PE:-0.29

High:0.1263

Open:0.1150

Low:0.1057

Close:0.1188

Loading ...

Overview Company News Filings

TriMas Packaging Group to Exhibit at Paris Packaging Week and LUXE PACK Los Angeles 2025

Dr Boreham’s Crucible: Radiopharm hopes to turn up the sweet sound of success

Guess which ASX 200 stock is jumping to record high on big European news

LNTH: LMI Acquisition and NeuraCeq

Zacks Small Cap Research

Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

BDSX Stock Rises After Publication of Study Data for Nodify CDT Test

Cassava Sciences Provides a Business Update

Press Release: HydroGraph Publishes 2025 CEO Letter to Shareholders

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

Malaysia imposes provisional anti-dumping duties on PET imports from China, Indonesia

Health Check: Telix CEO gets pay bump as company files for US kidney imaging approval

Considering delayed non-dilutive sources of financing, CARBIOS postpones construction of its Longlaville PET biorecycling plant for 6 to 9 months

Contineum initiates patient dosing in Phase 1B PET trial

Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791

AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome

CVM: CRO Selected for Registrational Trial

Zacks Small Cap Research

Pet Valu Holdings Ltd. (PET) Gets a Buy from Barclays

Investing in a World of Options and Asymmetry

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PET/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PET","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PET\",,,,,undefined,":{"symbol":"PET","market":"US","secType":"STK","nameCN":"Wag! Group Co","latestPrice":0.1144,"timestamp":1744920000000,"preClose":0.1188,"halted":0,"volume":521406,"hourTrading":{"tag":"盘后","latestPrice":0.1181,"preClose":0.1144,"latestTime":"19:38 EDT","volume":614,"amount":72.5464,"timestamp":1744933088636},"delay":0,"floatShares":22064454,"shares":50733823,"eps":-0.392853,"marketStatus":"Closed Good Friday","change":-0.0044,"latestTime":"04-17 16:00:00 EDT","open":0.115,"high":0.1263,"low":0.1057,"amount":58654.75457664,"amplitude":0.173401,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.392853,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1188,"preHourTrading":{"tag":"盘前","latestPrice":0.1256,"preClose":0.1188,"latestTime":"09:29 EDT","volume":3559,"amount":430.227988885,"timestamp":1744896551176},"postHourTrading":{"tag":"盘后","latestPrice":0.1181,"preClose":0.1144,"latestTime":"19:38 EDT","volume":614,"amount":72.5464,"timestamp":1744933088636},"volumeRatio":1.701625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PET\",,,,,undefined,":{"symbol":"PET","floatShares":22064454,"roa":"-16.97%","roe":"-3036.82%","lyrEps":-0.392853,"volumeRatio":1.701625,"shares":50733823,"dividePrice":0,"high":0.1263,"amplitude":0.173401,"preClose":0.1188,"low":0.1057,"week52Low":0.1035,"pbRate":"-11.87","psRate":"0.08","week52High":2.47,"institutionHeld":0,"latestPrice":0.1144,"eps":-0.392853,"divideRate":0,"volume":521406,"delay":0,"ttmEps":-0.392853,"open":0.115,"prevYearClose":0.2383,"prevWeekClose":0.1278,"prevMonthClose":0.1531,"prevQuarterClose":0.1531,"fiveDayClose":0.1273,"twentyDayClose":0.2355,"sixtyDayClose":0.2622},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PET\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2505272521","title":"TriMas Packaging Group to Exhibit at Paris Packaging Week and LUXE PACK Los Angeles 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2505272521","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505272521?lang=en_us&edition=fundamental","pubTime":"2025-01-21 23:00","pubTimestamp":1737471600,"startTime":"0","endTime":"0","summary":"BLOOMFIELD HILLS, Mich., January 21, 2025----TriMas Packaging, the largest operating group of TriMas , is excited to announce its participation in two upcoming trade shows, where the Company will showcase its diverse portfolio of innovative and sustainable dispensing and closure product solutions.TriMas Packaging will be attending the following trade shows:. TriMas Packaging serves its global customers with its market-leading brands, consisting of Rieke, Affaba & Ferrari, Rapak, Taplast, Plastic Srl and Aarts Packaging. TriMas Packaging designs and manufactures a comprehensive array of dispensing, closure and flexible packaging solutions for a broad range of end markets including the beauty and personal care, food and beverage, home care, pharmaceutical and nutraceutical, and industrial and agricultural markets. With approximately 2,200 dedicated employees and 26 locations worldwide, TriMas Packaging’s innovative solutions and services are designed to enhance customers’ ability to disp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/trimas-packaging-group-exhibit-paris-150000035.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4126","BK4136","TRS","LU0029874061.USD","PET","BK4192","LU0128526141.USD","PACK","PP"],"gpt_icon":0},{"id":"2505375932","title":"Dr Boreham’s Crucible: Radiopharm hopes to turn up the sweet sound of success","url":"https://stock-news.laohu8.com/highlight/detail?id=2505375932","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505375932?lang=en_us&edition=fundamental","pubTime":"2025-01-21 04:30","pubTimestamp":1737405007,"startTime":"0","endTime":"0","summary":"Viewed as a ‘mini me’ version of the all-conquering Telix Pharmaceuticals, the $60 million market cap Radiopharm Theranostics (ASX:RAD) is emerging from unloved status to that of a genuine contender i","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/09/boreham-csl-1200_x_675-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/09/boreham-csl-1200_x_675-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/dr-borehams-crucible-radiopharm-hopes-to-turn-up-the-sweet-sound-of-success/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BK4192","PET"],"gpt_icon":0},{"id":"2504597844","title":"Guess which ASX 200 stock is jumping to record high on big European news","url":"https://stock-news.laohu8.com/highlight/detail?id=2504597844","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504597844?lang=en_us&edition=fundamental","pubTime":"2025-01-17 07:18","pubTimestamp":1737069517,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals Ltd  shares are ending the week on a positive note. In morning trade on Friday, the ASX 200 healthcare stock is up 4.5% to a record high of $27.00. Why is this ASX 200 healthcare stock racing higher?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/17/guess-which-asx-200-stock-is-jumping-to-record-high-on-big-european-news/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4215","BCR","BK4588","TGA","DCP","LU1894683264.USD","TLX.AU","RMS.AU","BK7104","PET","BK4213","BK7047","BK4585","BK4144","PET.AU","LU2637428348.USD","LU2346227817.USD","BK7506","CMS","BK4208","EEA","BK4192","TGA.AU","BK7067","BK7001","LU1894683348.USD","MAA"],"gpt_icon":0},{"id":"2503503182","title":"LNTH: LMI Acquisition and NeuraCeq","url":"https://stock-news.laohu8.com/highlight/detail?id=2503503182","media":"Zacks Small Cap Research","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503503182?lang=en_us&edition=fundamental","pubTime":"2025-01-14 19:13","pubTimestamp":1736853180,"startTime":"0","endTime":"0","summary":"Lantheus Holdings, Inc.  announced its intent to acquire Life Molecular Imaging Ltd.  for $350 million in cash and an additional $400 million in potential earn out and milestone payments. LMI sole commercial product is NeuraCeq, a globally approved[1] F-18 radioactive diagnostic agent for positron emission tomography  imaging of the brain to evaluate β-amyloid neuritic plaque density. Neuraceq was approved in 2014 and is protected by various patents that expire over the years of 2029 to 2032. The deal also includes LMI’s commercialization force and five development candidates including a Tau agent designated PI-2620. Details of the transaction were included in a press release and Form 8-K filing. A conference call was held on January 13th providing additional color. The transaction is expected to close in 2H:25.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lnth-lmi-acquisition-neuraceq-111300771.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4192","PET","BK4198","LNTH","BK4585"],"gpt_icon":0},{"id":"2503344418","title":"Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2503344418","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503344418?lang=en_us&edition=fundamental","pubTime":"2025-01-13 13:05","pubTimestamp":1736744700,"startTime":"0","endTime":"0","summary":"Enhances Lantheus’ growth profile with Neuraceq, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s Disease Advances Lantheus’ radioph","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/13/3008099/0/en/Lantheus-to-Acquire-Life-Molecular-Imaging-for-an-Upfront-Payment-of-350-Million-to-Accelerate-Innovation-for-Patients-in-the-Growing-Alzheimer-s-Disease-Radiodiagnostic-Market.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNTH","PET","BK4192","AAQC","BK4588","BK4585","BK4198"],"gpt_icon":0},{"id":"2503978553","title":"Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2503978553","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503978553?lang=en_us&edition=fundamental","pubTime":"2025-01-13 06:04","pubTimestamp":1736719440,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, Jan.  13, 2025  (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has entered into an asset purcha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/12/3008077/0/en/Telix-to-Acquire-Next-Generation-Therapeutic-Assets-and-Innovative-Biologics-Technology-Platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","BK4543","TLX","BK4213","TGA","PET","ASX","BK4526","BK4141","BK4139"],"gpt_icon":0},{"id":"2502015616","title":"Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2502015616","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502015616?lang=en_us&edition=fundamental","pubTime":"2025-01-09 20:00","pubTimestamp":1736424000,"startTime":"0","endTime":"0","summary":"In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing Phase 2a trial in focal epilepsy; restricted neuroanatomica","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/09/3006949/0/en/Rapport-Therapeutics-Announces-New-Phase-1-Data-Further-Supporting-RAP-219-s-Transformative-Potential-for-CNS-Disorders.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","PET","BK4129","BK4139","ECG","BK4192","LENZ","BK4007","CNS","RAPP","PK","BK4218","BK4181"],"gpt_icon":0},{"id":"2501899727","title":"BDSX Stock Rises After Publication of Study Data for Nodify CDT Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2501899727","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501899727?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:30","pubTimestamp":1736339400,"startTime":"0","endTime":"0","summary":"Biodesix, Inc. BDSX recently announced anew post-market clinical validation study, publishedinCHEST Pulmonary Journal. The study reaffirms the previously established performance of the BDSX’s Nodify CDTblood-based lung nodule test.The Nodify CDT test is a blood-based diagnostic tool designed to detect cancer-associated autoantibodies, aiding in the identification of lung nodules that may be malignant. It helps healthcare providers prioritize patients for further diagnostic evaluation, potentially reducing unnecessary invasive procedures.Following the announcement, shares of the company moved north 2.7% and closed at $1.49 on Tuesday. In the past year, BDSX’s shares have lost 24.7% compared with the industry’s growth of 3.9%. The S&P 500 has gained 24.4% in the same time frame.The study found that the Nodify CDT test had high specificity, accurately identifying benign lung nodules as low risk, outperforming positron emission tomography  scans, which had more false positives. False posit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bdsx-stock-rises-publication-study-123000579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1061106388.HKD","ABT","LU1691799644.USD","LU0205193047.USD","LU2764262908.HKD","LU2112291526.USD","CDT","LU2237957811.SGD","BK4592","LU2089984988.USD","PET","IE0002141913.USD","LU0122379950.USD","LU0234572021.USD","BK4196","BK4585","LU2764263039.SGD","SG9999004303.SGD","SGXZ23171101.USD","LU0868494617.USD","IE00B2B36J28.USD","BK4588","LU1721429741.USD","IE0009355771.USD","LU0170899867.USD","BK4192","IE00BJT1NW94.SGD","SG9999002232.USD","MASI","LU2237957902.USD","LU1057294990.SGD","BK4082","BK4581","LU0205194284.USD","BK4121","SG9999002224.SGD","BK4568","LU2468319806.SGD","BDSX","LU1989763690.USD","BK4566","LU0240877869.USD","BK4533","LU1914381329.SGD","LU2720916845.USD","ARAY","LU1989763427.SGD","LU0266013472.USD","LU1023059063.AUD","LU0240878834.USD"],"gpt_icon":0},{"id":"2501475826","title":"Cassava Sciences Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2501475826","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501475826?lang=en_us&edition=fundamental","pubTime":"2025-01-08 05:30","pubTimestamp":1736285400,"startTime":"0","endTime":"0","summary":"Topline data from Phase 3 REFOCUS-ALZ study of simufilam in patients with mild-to-moderate Alzheimer’s disease expected late first-quarter/early second-quarter 2025 Implementing cost curtailment inclu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/07/3005863/8339/en/Cassava-Sciences-Provides-a-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAVA","BK4192","BK4601","ETH","BK4585","BK4588","BK4007","BK4547","PET"],"gpt_icon":0},{"id":"2501270583","title":"Press Release: HydroGraph Publishes 2025 CEO Letter to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2501270583","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501270583?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:00","pubTimestamp":1736251200,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, Jan. 07, 2025  -- HydroGraph Clean Power Inc.    a sustainable commercial manufacturer of pristine graphene, today issued a letter to shareholders from President & CEO, Kjirstin Breure.As we enter 2025, on behalf of HydroGraph I would like to take a moment to wish you a Happy New Year. You have played an important role in helping us advance projects across all areas of our business over the past few years, and I look forward to sharing more of our accomplishments in the year ahead.Looking back on 2024, I am proud of the significant progress the HydroGraph team has made to differentiate our proprietary capabilities and position us as the leading sustainable producer of pristine graphene. We advanced our application development work, established new partnerships, and opened new performance driven commercial relationships through advanced testing and small batch  production of our high-quality graphene.biomedical sensor aimed at the early detection of lung can","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","HGRAF","BK4232","R","PET","BK4022"],"gpt_icon":0},{"id":"2501271615","title":"Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2501271615","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501271615?lang=en_us&edition=fundamental","pubTime":"2025-01-07 19:00","pubTimestamp":1736247600,"startTime":"0","endTime":"0","summary":"Analysis of 447 patients receiving the Nodify CDT blood-based lung nodule test published in CHEST Pulmonary Journal reaffirms test performance. LOUISVILLE, Colo., Jan. 07, 2025  -- Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced a new post-market clinical validation study was published in CHEST Pulmonary Journal that reaffirms the previously established performance of the Nodify CDT blood-based lung nodule test. Clinical data is one of the foundational pillars driving the success of Biodesix through market adoption and payor coverage of its diagnostic tests.“It is very encouraging to see that the performance of the test is robust in further validation studies,” commented Gerard A. Silvestri, MD, MS, Hillenbrand Professor of Thoracic Oncology at the Medical University of South Carolina. “Clinicians often rely on PET scans for risk classification, but this study demonstrates that the performance of PET alone is insufficient for diagnostic d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biodesix-announces-publication-nodify-cdt-110000871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","BK4192","PET","BK4121","BDSX","CDT"],"gpt_icon":0},{"id":"2501312270","title":"Malaysia imposes provisional anti-dumping duties on PET imports from China, Indonesia","url":"https://stock-news.laohu8.com/highlight/detail?id=2501312270","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501312270?lang=en_us&edition=fundamental","pubTime":"2025-01-07 11:36","pubTimestamp":1736220979,"startTime":"0","endTime":"0","summary":"The duties range from 6.33 to 37.44% and will remain in force for a maximum of 120 days","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/international/asean/malaysia-imposes-provisional-anti-dumping-duties-pet-imports-china-indonesia","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/international/asean/malaysia-imposes-provisional-anti-dumping-duties-pet-imports-china-indonesia","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["BK4192","PET"],"gpt_icon":0},{"id":"2495508495","title":"Health Check: Telix CEO gets pay bump as company files for US kidney imaging approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2495508495","media":"Stockheads","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495508495?lang=en_us&edition=fundamental","pubTime":"2024-12-30 09:58","pubTimestamp":1735523900,"startTime":"0","endTime":"0","summary":"Telix has filed for FDA approval of its next key nuclear imaging tool. Dimerix reaches a key recruitment milestone in its phase III kidney disease trial. Proteomics shares bound 20% after endometriosis diagnosis breakthrough","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/12/GettyImages-1295941134-1200x675-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/12/GettyImages-1295941134-1200x675-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/health-check-telix-ceo-gets-pay-bump-as-company-files-for-us-kidney-imaging-approval/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BK4192","FSGS","BK4213","PET","TGA"],"gpt_icon":0},{"id":"2492143129","title":"Considering delayed non-dilutive sources of financing, CARBIOS postpones construction of its Longlaville PET biorecycling plant for 6 to 9 months","url":"https://stock-news.laohu8.com/highlight/detail?id=2492143129","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492143129?lang=en_us&edition=fundamental","pubTime":"2024-12-19 15:45","pubTimestamp":1734594300,"startTime":"0","endTime":"0","summary":"Considering delayed non-dilutive sources of financing, CARBIOS postpones construction of its Longlaville PET biorecycling plant for 6 to 9 months. CARBIOS maintains a robust available cash position of 112 million euros on 30 November 2024. CARBIOS confirms major advances in commercial contract negotiations and makes changes to its Governance. CARBIOS is speeding up its discussions with public stakeholders and private investors. The subsidies obtained under the France 2030 bid operated by ADEME have been approved; their release is pending authorization of the state aid scheme by the European Commission.CARBIOS is pursuing its growth strategy and is confident of rapidly securing several major binding commercial contracts in the first half of 2025. Philippe Pouletty, founder, Chairman of the Board of Directors and new interim CEO of CARBIOS, comments: “To ensure the prudent execution of our strategy and safeguard our cash flow in a complex environment, we are postponing construction of th","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0fNJZseJkcOdGRyu92iluA--~B/aD0xMzg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0639471fb404058fcb6673a935fe5510","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0fNJZseJkcOdGRyu92iluA--~B/aD0xMzg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0639471fb404058fcb6673a935fe5510"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/considering-delayed-non-dilutive-sources-074500153.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4192","COOSF","BK4090","PET"],"gpt_icon":0},{"id":"2492640239","title":"Contineum initiates patient dosing in Phase 1B PET trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492640239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492640239?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:11","pubTimestamp":1734383485,"startTime":"0","endTime":"0","summary":"Contineum (CTNM) Therapeutics “announced dosing of the first cohort of patients in the PIPE-791 Phase 1b positron emission tomography, PET, trial. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/contineum-initiates-patient-dosing-in-phase-1b-pet-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/contineum-initiates-patient-dosing-in-phase-1b-pet-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTNM","BK4192","PET","BK4007"],"gpt_icon":0},{"id":"2492628336","title":"Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791","url":"https://stock-news.laohu8.com/highlight/detail?id=2492628336","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492628336?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:05","pubTimestamp":1734383100,"startTime":"0","endTime":"0","summary":"- Phase 1b trial will evaluate receptor occupancy of PIPE-791 in the brain and lungs of patients in multiple cohorts using a PET tracer of the LPA1 receptor. - Topline data readout planned for the second quarter of 2025. SAN DIEGO, December 16, 2024----Contineum Therapeutics, Inc.  , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments in the treatment of neuroscience, inflammation and immunology  indications, today announced dosing of the first cohort of patients in the PIPE-791 Phase 1b positron emission tomography  trial. PIPE-791 is a novel, brain penetrant, small molecule antagonist of the lysophosphatidic acid 1 receptor .","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/l3SnSMZbj0QxZ95HB.Zg_g--~B/aD02NjM7dz0xODc1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7f3fb574253c92b8083daad88dae0200","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/l3SnSMZbj0QxZ95HB.Zg_g--~B/aD02NjM7dz0xODc1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7f3fb574253c92b8083daad88dae0200"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/contineum-therapeutics-initiates-patient-dosing-210500864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4192","BK4007","CTNM","BK4139","LENZ","PET"],"gpt_icon":0},{"id":"2490944020","title":"AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2490944020","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490944020?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:00","pubTimestamp":1733832000,"startTime":"0","endTime":"0","summary":"AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome  ACI-24.060 was generally safe and well tolerated in individuals with Down syndrome with no serious adv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/10/2994352/0/en/AC-Immune-Reports-Interim-Safety-Data-from-Phase-1b-2-ABATE-Trial-of-ACI-24-060-in-Down-syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACI","BK4139","BK4192","BK4539","PET","ARIA","ACIU","BK4113","BK4135","BK4585","BK4588","AC","BK4023"],"gpt_icon":1},{"id":"2490502776","title":"CVM: CRO Selected for Registrational Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2490502776","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490502776?lang=en_us&edition=fundamental","pubTime":"2024-12-09 17:39","pubTimestamp":1733737140,"startTime":"0","endTime":"0","summary":"CEL-SCI Corporation  has made progress advancing the prerequisites for the upcoming registrational trial, selecting the contract research organization  that will run it and coming to an agreement with the FDA on which biomarkers are appropriate for selecting patients. The view of oncologists as expressed by the FDA’s ODAC is that using checkpoint inhibitors to treat low PD-L1 expressing patients provides limited efficacy and could even be harmful. This view opens the door for the use of Multikine, if approved, in the low expressing PD-L1 patient population based on its efficacy in this group.FDA ODAC opines against use of checkpoints in low PD-L1 expression patients – October 2024. FDA agrees to use of PD-L1 biomarker in Multikine registration study – November 2024. The 79 patients who were recommended to receive only radiotherapy benefited to an even greater degree from pre-surgery treatment with Multikine compared to the wider 114 patient group. This target low risk population  had a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvm-cro-selected-registrational-trial-093900095.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PET","BK4139","BK4097","BK4192","OS","CVM"],"gpt_icon":0},{"id":"2489469858","title":"Pet Valu Holdings Ltd. (PET) Gets a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2489469858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489469858?lang=en_us&edition=fundamental","pubTime":"2024-12-05 23:51","pubTimestamp":1733413900,"startTime":"0","endTime":"0","summary":"Barclays analyst Adrienne Yih maintained a Buy rating on Pet Valu Holdings Ltd. (PET – Research Report) yesterday and set a price target of C$27.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pet-valu-holdings-ltd-pet-gets-a-buy-from-barclays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pet-valu-holdings-ltd-pet-gets-a-buy-from-barclays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PET","BK4192"],"gpt_icon":0},{"id":"2489432650","title":"Investing in a World of Options and Asymmetry","url":"https://stock-news.laohu8.com/highlight/detail?id=2489432650","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489432650?lang=en_us&edition=fundamental","pubTime":"2024-12-05 20:01","pubTimestamp":1733400077,"startTime":"0","endTime":"0","summary":"“The secret to wealth is finding the asymmetric payoff—small risk, big reward” Nassim Taleb. When this writer first set about a career in finance we were tasked with uncovering how much each ASX energy company was worth, with little more direction than a basic understanding of discounted cash flows and net present values. The task was easy enough; to develop an asset by asset model that delivered a valuation per share, but how do you consider:. Specifically when it comes to oil and gas we were utilising it in the pricing of exploration plays. How does this work?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/investing-in-a-world-of-options-and-asymmetry","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/investing-in-a-world-of-options-and-asymmetry","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["MTR","BK7053","NEU","IE00B2PGVK34.USD","BK7050","LU0472753341.HKD","BK7507","BK7503","BK4133","AS","BK4211","CU6.AU","MIN.AU","LU0124676726.USD","LU2506952410.USD","LU2477742899.HKD","BK7096","BK7067","LU2506952337.HKD","BK7508","BK7504","LU0689626769.HKD","ASB","LU0289961442.SGD","LU0289739343.SGD","AFL.AU","IE00BDGV0183.EUR","IMR.AU","MTR.AU","LU0511384066.AUD","ASB.AU","BK7115","IE00BVYPNV92.GBP","PET","IE00B3CCJ633.GBP","AFL","OPC.AU","TLX.AU","PET.AU","BK4162","WTC.AU","NEU.AU","TLX","TAM.AU","ORA","BK7502","BOT.AU","IE00B3PB1722.GBP","ORA.AU","MIN"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":121,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PET\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-24","symbol":"PET","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2024-11-13","symbol":"PET","fiscalQuarterEnding":"2024/09","expectedEps":-0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2024-08-07","symbol":"PET","fiscalQuarterEnding":"2024/06","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.06},{"date":"2024-07-10","symbol":"PET","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1720598400000,"name":null,"time":"Pre-Market","dateTimestamp":1720584000000,"actualEps":null},{"market":"US","date":"2024-05-09","symbol":"PET","fiscalQuarterEnding":"2024/03","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PET\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PET\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1731643200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PET\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PET","date":"2025-04-16","current":-0.355206,"percent":0.996528,"low":-51.918761,"twenty":-24.608818,"median":-4.572017,"eighty":-1.885076,"high":-0.321418,"avg":-10.255692,"sd":10.929967,"marketCap":6240260},"quantilePoints":[{"date":"2021-10-01","current":-7.916755,"twenty":-7.916755,"median":-7.908627,"eighty":-7.901458,"marketCap":149143750},{"date":"2021-10-08","current":-7.941139,"twenty":-7.942895,"median":-7.928947,"eighty":-7.908627,"marketCap":149603125},{"date":"2021-10-15","current":-7.900499,"twenty":-7.941172,"median":-7.916755,"eighty":-7.900499,"marketCap":148837500},{"date":"2021-10-22","current":-7.908627,"twenty":-7.941139,"median":-7.908627,"eighty":-7.900499,"marketCap":148990625},{"date":"2021-10-29","current":-7.908627,"twenty":-7.934637,"median":-7.908627,"eighty":-7.900499,"marketCap":148990625},{"date":"2021-11-05","current":-7.941139,"twenty":-7.941139,"median":-7.916755,"eighty":-7.900499,"marketCap":149603125},{"date":"2021-11-12","current":-7.949267,"twenty":-7.941139,"median":-7.924883,"eighty":-7.907001,"marketCap":149756250},{"date":"2021-11-19","current":-7.965524,"twenty":-7.949267,"median":-7.933011,"eighty":-7.908627,"marketCap":150062500},{"date":"2021-11-26","current":-8.185579,"twenty":-7.949267,"median":-7.933011,"eighty":-7.908627,"marketCap":154208125},{"date":"2021-12-03","current":-8.143943,"twenty":-7.965524,"median":-7.941139,"eighty":-7.908627,"marketCap":153423750},{"date":"2021-12-10","current":-8.110635,"twenty":-8.123958,"median":-7.941139,"eighty":-7.908627,"marketCap":152796250},{"date":"2021-12-17","current":-8.111634,"twenty":-8.143943,"median":-7.941139,"eighty":-7.908627,"marketCap":152815075},{"date":"2021-12-23","current":-8.135616,"twenty":-8.143943,"median":-7.949267,"eighty":-7.908627,"marketCap":153266875},{"date":"2021-12-31","current":-8.143943,"twenty":-8.143943,"median":-7.949267,"eighty":-7.911878,"marketCap":153423750},{"date":"2022-01-07","current":-25.77251,"twenty":-8.143943,"median":-7.957396,"eighty":-7.916755,"marketCap":153423750},{"date":"2022-01-14","current":-25.746157,"twenty":-8.168925,"median":-7.965524,"eighty":-7.916755,"marketCap":153266875},{"date":"2022-01-21","current":-25.746157,"twenty":-8.185579,"median":-7.977716,"eighty":-7.918381,"marketCap":153266875},{"date":"2022-01-28","current":-25.746157,"twenty":-25.693453,"median":-8.111634,"eighty":-7.924883,"marketCap":153266875},{"date":"2022-02-04","current":-25.825214,"twenty":-25.746157,"median":-8.115298,"eighty":-7.926509,"marketCap":153737500},{"date":"2022-02-11","current":-25.956975,"twenty":-25.746157,"median":-8.135616,"eighty":-7.933011,"marketCap":154521875},{"date":"2022-02-18","current":-25.904271,"twenty":-25.746157,"median":-8.143943,"eighty":-7.933011,"marketCap":154208125},{"date":"2022-02-25","current":-25.851566,"twenty":-25.77251,"median":-8.143943,"eighty":-7.933011,"marketCap":153894375},{"date":"2022-03-04","current":-25.930623,"twenty":-25.77251,"median":-8.143943,"eighty":-7.933011,"marketCap":154365000},{"date":"2022-03-11","current":-25.956975,"twenty":-25.825214,"median":-8.143943,"eighty":-7.941139,"marketCap":154521875},{"date":"2022-03-18","current":-26.115089,"twenty":-25.825214,"median":-8.160598,"eighty":-7.941139,"marketCap":155463125},{"date":"2022-03-25","current":-26.036032,"twenty":-25.851566,"median":-8.177252,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-01","current":-26.036032,"twenty":-25.877919,"median":-8.185579,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-08","current":-26.036032,"twenty":-25.904271,"median":-16.939516,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-14","current":-26.220498,"twenty":-25.956975,"median":-25.700041,"eighty":-7.941139,"marketCap":156090625},{"date":"2022-04-22","current":-26.036032,"twenty":-25.956975,"median":-25.746157,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-29","current":-26.088737,"twenty":-26.00968,"median":-25.746157,"eighty":-7.941269,"marketCap":155306250},{"date":"2022-05-06","current":-26.036032,"twenty":-26.01495,"median":-25.746157,"eighty":-7.947674,"marketCap":154992500},{"date":"2022-05-13","current":-24.509388,"twenty":-26.01495,"median":-25.746157,"eighty":-7.949267,"marketCap":154678750},{"date":"2022-05-20","current":-24.534246,"twenty":-26.00968,"median":-25.746157,"eighty":-7.949267,"marketCap":154835625},{"date":"2022-05-27","current":-24.68339,"twenty":-26.00968,"median":-25.719805,"eighty":-7.949267,"marketCap":155776875},{"date":"2022-06-03","current":-24.68339,"twenty":-26.00968,"median":-25.693453,"eighty":-7.949267,"marketCap":155776875},{"date":"2022-06-10","current":-24.583961,"twenty":-26.00968,"median":-24.68339,"eighty":-7.954144,"marketCap":155149375},{"date":"2022-06-17","current":-24.608818,"twenty":-26.00968,"median":-24.68339,"eighty":-7.957396,"marketCap":155306250},{"date":"2022-06-24","current":-24.708248,"twenty":-25.988598,"median":-24.68339,"eighty":-7.960647,"marketCap":155933750},{"date":"2022-07-01","current":-24.608818,"twenty":-25.956975,"median":-24.658533,"eighty":-7.965524,"marketCap":155306250},{"date":"2022-07-08","current":-24.733105,"twenty":-25.956975,"median":-24.658533,"eighty":-7.96715,"marketCap":156090625},{"date":"2022-07-15","current":-24.757962,"twenty":-25.956975,"median":-24.68339,"eighty":-7.975278,"marketCap":156247500},{"date":"2022-07-22","current":-24.807677,"twenty":-25.956975,"median":-24.68339,"eighty":-8.007551,"marketCap":156561250},{"date":"2022-07-29","current":-25.105966,"twenty":-25.956975,"median":-24.68339,"eighty":-8.110835,"marketCap":158443750},{"date":"2022-08-05","current":-19.587625,"twenty":-25.956975,"median":-24.68339,"eighty":-8.111634,"marketCap":123617500},{"date":"2022-08-12","current":-46.571248,"twenty":-25.956975,"median":-24.68339,"eighty":-8.111634,"marketCap":293911149},{"date":"2022-08-19","current":-31.187311,"twenty":-26.00968,"median":-24.68339,"eighty":-8.1131,"marketCap":196823120},{"date":"2022-08-26","current":-29.685032,"twenty":-26.00968,"median":-24.708248,"eighty":-8.118962,"marketCap":187342238},{"date":"2022-09-02","current":-34.550721,"twenty":-26.036032,"median":-24.733105,"eighty":-8.122293,"marketCap":159278826},{"date":"2022-09-09","current":-42.365766,"twenty":-26.036032,"median":-24.757962,"eighty":-8.135616,"marketCap":195306179},{"date":"2022-09-16","current":-44.175565,"twenty":-26.036032,"median":-24.78282,"eighty":-8.135616,"marketCap":203649356},{"date":"2022-09-23","current":-20.154587,"twenty":-26.036032,"median":-24.78282,"eighty":-8.143943,"marketCap":92912648},{"date":"2022-09-30","current":-16.864043,"twenty":-26.036032,"median":-24.745534,"eighty":-8.143943,"marketCap":77743236},{"date":"2022-10-07","current":-20.812696,"twenty":-26.036032,"median":-24.733105,"eighty":-8.143943,"marketCap":95946530},{"date":"2022-10-14","current":-24.020978,"twenty":-26.036032,"median":-24.708248,"eighty":-8.143943,"marketCap":110736707},{"date":"2022-10-21","current":-32.45159,"twenty":-26.036032,"median":-24.733105,"eighty":-8.143943,"marketCap":149601831},{"date":"2022-10-28","current":-34.873351,"twenty":-26.036032,"median":-24.745534,"eighty":-8.143943,"marketCap":160766146},{"date":"2022-11-04","current":-27.317458,"twenty":-26.115089,"median":-24.78282,"eighty":-8.143943,"marketCap":125933481},{"date":"2022-11-11","current":-2.304056,"twenty":-26.115089,"median":-24.78282,"eighty":-8.143943,"marketCap":108509519},{"date":"2022-11-18","current":-2.038504,"twenty":-26.115089,"median":-24.757962,"eighty":-8.143943,"marketCap":96003337},{"date":"2022-11-25","current":-1.9604,"twenty":-26.115089,"median":-24.733105,"eighty":-8.132285,"marketCap":92325048},{"date":"2022-12-02","current":-1.991642,"twenty":-26.094007,"median":-24.708248,"eighty":-8.111634,"marketCap":93796364},{"date":"2022-12-09","current":-1.62846,"twenty":-26.046573,"median":-24.68339,"eighty":-7.972026,"marketCap":76692321},{"date":"2022-12-16","current":-1.679227,"twenty":-26.036032,"median":-24.68339,"eighty":-7.95577,"marketCap":79083209},{"date":"2022-12-23","current":-2.436832,"twenty":-26.036032,"median":-24.658533,"eighty":-7.949267,"marketCap":114762610},{"date":"2022-12-30","current":-2.405591,"twenty":-26.036032,"median":-24.658533,"eighty":-7.941139,"marketCap":113291295},{"date":"2023-01-06","current":-2.069667,"twenty":-26.036032,"median":-24.633675,"eighty":-7.941139,"marketCap":97470974},{"date":"2023-01-13","current":-2.218142,"twenty":-26.036032,"median":-24.621246,"eighty":-7.933011,"marketCap":104463401},{"date":"2023-01-20","current":-2.17128,"twenty":-26.036032,"median":-24.608818,"eighty":-7.926509,"marketCap":102256428},{"date":"2023-01-27","current":-2.530556,"twenty":-26.036032,"median":-24.608818,"eighty":-7.916755,"marketCap":119176557},{"date":"2023-02-03","current":-2.155659,"twenty":-26.036032,"median":-24.608818,"eighty":-7.908627,"marketCap":101520770},{"date":"2023-02-10","current":-1.851055,"twenty":-26.036032,"median":-24.608818,"eighty":-7.902125,"marketCap":87175444},{"date":"2023-02-17","current":-1.874486,"twenty":-26.036032,"median":-24.571532,"eighty":-7.893997,"marketCap":88278931},{"date":"2023-02-24","current":-2.245322,"twenty":-26.036032,"median":-24.559103,"eighty":-2.530556,"marketCap":86595328},{"date":"2023-03-03","current":-2.245322,"twenty":-26.036032,"median":-24.534246,"eighty":-2.452453,"marketCap":86595328},{"date":"2023-03-10","current":-1.614721,"twenty":-26.036032,"median":-24.534246,"eighty":-2.413401,"marketCap":62274938},{"date":"2023-03-17","current":-1.94913,"twenty":-26.036032,"median":-24.534246,"eighty":-2.38997,"marketCap":75172115},{"date":"2023-03-24","current":-2.197549,"twenty":-26.036032,"median":-24.509388,"eighty":-2.340867,"marketCap":84752874},{"date":"2023-03-31","current":-2.140222,"twenty":-26.036032,"median":-24.020978,"eighty":-2.293095,"marketCap":82541930},{"date":"2023-04-06","current":-2.111558,"twenty":-26.036032,"median":-23.445132,"eighty":-2.245322,"marketCap":81436457},{"date":"2023-04-14","current":-2.159331,"twenty":-26.036032,"median":-22.561,"eighty":-2.225952,"marketCap":83278911},{"date":"2023-04-21","current":-2.203009,"twenty":-26.01495,"median":-21.964387,"eighty":-2.217056,"marketCap":84963432},{"date":"2023-04-28","current":-2.270943,"twenty":-26.00968,"median":-20.697308,"eighty":-2.210332,"marketCap":87583450},{"date":"2023-05-05","current":-2.021661,"twenty":-26.00968,"median":-19.99006,"eighty":-2.209686,"marketCap":77969386},{"date":"2023-05-12","current":-2.248784,"twenty":-26.00968,"median":-19.907797,"eighty":-2.209686,"marketCap":89960352},{"date":"2023-05-19","current":-2.248784,"twenty":-26.00968,"median":-19.587625,"eighty":-2.209686,"marketCap":89960352},{"date":"2023-05-26","current":-1.874257,"twenty":-26.00968,"median":-19.301764,"eighty":-2.197549,"marketCap":74977784},{"date":"2023-06-02","current":-2.174138,"twenty":-25.978057,"median":-18.097997,"eighty":-2.197549,"marketCap":86974229},{"date":"2023-06-09","current":-2.061683,"twenty":-25.956975,"median":-16.864043,"eighty":-2.186237,"marketCap":82475562},{"date":"2023-06-16","current":-2.127282,"twenty":-25.956975,"median":-8.185579,"eighty":-2.180933,"marketCap":85099784},{"date":"2023-06-23","current":-2.04294,"twenty":-25.956975,"median":-8.185579,"eighty":-2.17128,"marketCap":81725784},{"date":"2023-06-29","current":-1.958599,"twenty":-25.956975,"median":-8.185579,"eighty":-2.164767,"marketCap":78351784},{"date":"2023-07-07","current":-1.883628,"twenty":-25.956975,"median":-8.168925,"eighty":-2.16347,"marketCap":75352672},{"date":"2023-07-14","current":-1.893,"twenty":-25.956975,"median":-8.148107,"eighty":-2.155659,"marketCap":75727561},{"date":"2023-07-21","current":-2.04294,"twenty":-25.956975,"median":-8.143943,"eighty":-2.147849,"marketCap":81725784},{"date":"2023-07-28","current":-2.108539,"twenty":-25.956975,"median":-8.143943,"eighty":-2.139508,"marketCap":84350007},{"date":"2023-08-04","current":-2.267851,"twenty":-25.941164,"median":-8.143943,"eighty":-2.138794,"marketCap":90723118},{"date":"2023-08-11","current":-2.32208,"twenty":-25.920074,"median":-8.135616,"eighty":-2.137501,"marketCap":99345563},{"date":"2023-08-18","current":-2.075795,"twenty":-25.907779,"median":-8.118962,"eighty":-2.137501,"marketCap":88808739},{"date":"2023-08-25","current":-2.053134,"twenty":-25.904271,"median":-8.111634,"eighty":-2.127997,"marketCap":87839211},{"date":"2023-09-01","current":-1.840115,"twenty":-25.904271,"median":-8.046207,"eighty":-2.121113,"marketCap":78725651},{"date":"2023-09-08","current":-1.903567,"twenty":-25.903322,"median":-7.973652,"eighty":-2.112829,"marketCap":81440328},{"date":"2023-09-15","current":-1.758534,"twenty":-25.899527,"median":-7.965524,"eighty":-2.108539,"marketCap":75235351},{"date":"2023-09-22","current":-1.695082,"twenty":-25.877919,"median":-7.953331,"eighty":-2.093176,"marketCap":72520673},{"date":"2023-09-29","current":-1.740405,"twenty":-25.851566,"median":-7.949267,"eighty":-2.080425,"marketCap":74459729},{"date":"2023-10-06","current":-1.704146,"twenty":-25.851566,"median":-7.945284,"eighty":-2.069745,"marketCap":72908484},{"date":"2023-10-13","current":-1.676952,"twenty":-25.851566,"median":-7.941139,"eighty":-2.061683,"marketCap":71745051},{"date":"2023-10-20","current":-1.60933,"twenty":-25.851566,"median":-7.941139,"eighty":-2.052312,"marketCap":68851980},{"date":"2023-10-27","current":-1.568177,"twenty":-25.851566,"median":-7.941139,"eighty":-2.045204,"marketCap":67091318},{"date":"2023-11-03","current":-1.560563,"twenty":-25.851566,"median":-7.933011,"eighty":-2.038504,"marketCap":66765557},{"date":"2023-11-10","current":-16.478139,"twenty":-25.851566,"median":-7.933011,"eighty":-2.036475,"marketCap":66703507},{"date":"2023-11-17","current":-17.055401,"twenty":-25.841025,"median":-7.941139,"eighty":-2.038504,"marketCap":69040264},{"date":"2023-11-24","current":-17.063157,"twenty":-25.825214,"median":-7.941139,"eighty":-2.038504,"marketCap":69071661},{"date":"2023-12-01","current":-17.063157,"twenty":-25.825214,"median":-7.941139,"eighty":-2.039391,"marketCap":69071661},{"date":"2023-12-08","current":-16.966208,"twenty":-25.825214,"median":-7.949267,"eighty":-2.04294,"marketCap":68679208},{"date":"2023-12-15","current":-16.869258,"twenty":-25.825214,"median":-7.949267,"eighty":-2.04294,"marketCap":68286755},{"date":"2023-12-22","current":-17.257057,"twenty":-25.819944,"median":-7.957396,"eighty":-2.044072,"marketCap":69856566},{"date":"2023-12-29","current":-16.966208,"twenty":-25.804132,"median":-7.96146,"eighty":-2.047469,"marketCap":68679208},{"date":"2024-01-05","current":-17.063157,"twenty":-25.798862,"median":-7.965524,"eighty":-2.050085,"marketCap":69071661},{"date":"2024-01-12","current":-16.384509,"twenty":-25.798862,"median":-8.046207,"eighty":-2.052312,"marketCap":66324492},{"date":"2024-01-19","current":-17.450956,"twenty":-25.793592,"median":-8.111634,"eighty":-2.052312,"marketCap":70641471},{"date":"2024-01-26","current":-19.293002,"twenty":-25.77251,"median":-8.118962,"eighty":-2.052476,"marketCap":78098071},{"date":"2024-02-02","current":-19.370562,"twenty":-25.77251,"median":-8.135616,"eighty":-2.054844,"marketCap":78412033},{"date":"2024-02-09","current":-17.935705,"twenty":-25.77251,"median":-8.143943,"eighty":-2.061683,"marketCap":72603734},{"date":"2024-02-16","current":-6.45394,"twenty":-25.77251,"median":-8.143943,"eighty":-2.06328,"marketCap":85947123},{"date":"2024-02-23","current":-5.95295,"twenty":-25.77251,"median":-8.139779,"eighty":-2.069667,"marketCap":79275429},{"date":"2024-03-01","current":-5.894009,"twenty":-25.77251,"median":-8.118962,"eighty":-2.069745,"marketCap":78490524},{"date":"2024-03-08","current":-6.33606,"twenty":-25.746157,"median":-8.111634,"eighty":-2.069745,"marketCap":84377313},{"date":"2024-03-15","current":-6.12977,"twenty":-25.746157,"median":-8.110635,"eighty":-2.075795,"marketCap":81630144},{"date":"2024-03-22","current":-5.894009,"twenty":-25.746157,"median":-7.969588,"eighty":-2.077556,"marketCap":78490524},{"date":"2024-03-28","current":-5.658249,"twenty":-25.746157,"median":-7.96146,"eighty":-2.077556,"marketCap":75350903},{"date":"2024-04-05","current":-6.089301,"twenty":-25.746157,"median":-7.949267,"eighty":-2.079851,"marketCap":81091218},{"date":"2024-04-12","current":-6.392251,"twenty":-25.746157,"median":-7.949267,"eighty":-2.080425,"marketCap":85125607},{"date":"2024-04-19","current":-6.301366,"twenty":-25.746157,"median":-7.941302,"eighty":-2.084378,"marketCap":83915291},{"date":"2024-04-26","current":-6.664906,"twenty":-25.746157,"median":-7.941139,"eighty":-2.091032,"marketCap":88756558},{"date":"2024-05-03","current":-6.831529,"twenty":-25.746157,"median":-7.941139,"eighty":-2.093031,"marketCap":90975471},{"date":"2024-05-10","current":-7.133641,"twenty":-25.746157,"median":-7.937075,"eighty":-2.09797,"marketCap":98237372},{"date":"2024-05-17","current":-5.947142,"twenty":-25.746157,"median":-7.933011,"eighty":-2.099168,"marketCap":81898096},{"date":"2024-05-24","current":-4.687403,"twenty":-25.735616,"median":-7.924883,"eighty":-2.106665,"marketCap":64550224},{"date":"2024-05-31","current":-4.572017,"twenty":-25.71717,"median":-7.916755,"eighty":-2.108539,"marketCap":62961251},{"date":"2024-06-07","current":-4.572017,"twenty":-25.698723,"median":-7.908627,"eighty":-2.108539,"marketCap":62961251},{"date":"2024-06-14","current":-4.513024,"twenty":-25.693453,"median":-7.908627,"eighty":-2.108642,"marketCap":62148847},{"date":"2024-06-21","current":-4.365539,"twenty":-25.580927,"median":-7.908627,"eighty":-2.109349,"marketCap":60117839},{"date":"2024-06-28","current":-4.92598,"twenty":-25.355875,"median":-7.908627,"eighty":-2.110454,"marketCap":67835670},{"date":"2024-07-05","current":-4.719502,"twenty":-25.12088,"median":-7.900499,"eighty":-2.114099,"marketCap":64992259},{"date":"2024-07-12","current":-4.45403,"twenty":-24.996593,"median":-7.900499,"eighty":-2.119192,"marketCap":61336444},{"date":"2024-07-15","current":-4.719502,"twenty":-24.941907,"median":-7.900499,"eighty":-2.119832,"marketCap":64992259},{"date":"2024-08-02","current":-3.480633,"twenty":-24.88722,"median":-7.896435,"eighty":-2.120473,"marketCap":47931791},{"date":"2024-08-09","current":-3.44267,"twenty":-24.832534,"median":-7.872782,"eighty":-2.121113,"marketCap":41838766},{"date":"2024-08-16","current":-3.734947,"twenty":-24.812648,"median":-6.984832,"eighty":-2.126048,"marketCap":45390806},{"date":"2024-08-23","current":-3.084343,"twenty":-24.807677,"median":-6.876972,"eighty":-2.127282,"marketCap":37484020},{"date":"2024-08-30","current":-3.413661,"twenty":-24.787791,"median":-6.869398,"eighty":-2.127282,"marketCap":41486221},{"date":"2024-09-06","current":-3.375508,"twenty":-24.78282,"median":-6.801234,"eighty":-2.127997,"marketCap":41022551},{"date":"2024-09-13","current":-2.972696,"twenty":-24.767905,"median":-6.725496,"eighty":-2.129789,"marketCap":36127177},{"date":"2024-09-20","current":-3.449806,"twenty":-24.757962,"median":-6.635604,"eighty":-2.134259,"marketCap":41925487},{"date":"2024-09-27","current":-3.545388,"twenty":-24.743048,"median":-6.543726,"eighty":-2.136653,"marketCap":43087101},{"date":"2024-10-04","current":-3.48595,"twenty":-24.733105,"median":-6.48341,"eighty":-2.137501,"marketCap":42364752},{"date":"2024-10-11","current":-3.353821,"twenty":-24.733105,"median":-6.45394,"eighty":-2.13936,"marketCap":40758992},{"date":"2024-10-18","current":-3.413661,"twenty":-24.718191,"median":-6.392251,"eighty":-2.140222,"marketCap":41486221},{"date":"2024-10-25","current":-3.226914,"twenty":-24.708248,"median":-6.361956,"eighty":-2.143518,"marketCap":39216680},{"date":"2024-10-31","current":-2.961451,"twenty":-24.708248,"median":-6.331661,"eighty":-2.146569,"marketCap":35990517},{"date":"2024-11-08","current":-2.552615,"twenty":-24.698305,"median":-6.303978,"eighty":-2.147849,"marketCap":31021931},{"date":"2024-11-15","current":-0.547386,"twenty":-24.68339,"median":-6.27712,"eighty":-2.146569,"marketCap":8878051},{"date":"2024-11-22","current":-0.606003,"twenty":-24.68339,"median":-6.22989,"eighty":-2.137218,"marketCap":9828767},{"date":"2024-11-29","current":-0.659113,"twenty":-24.68339,"median":-6.184448,"eighty":-2.128912,"marketCap":10690153},{"date":"2024-12-06","current":-0.685514,"twenty":-24.68339,"median":-6.12977,"eighty":-2.122347,"marketCap":11118357},{"date":"2024-12-13","current":-0.70639,"twenty":-24.678419,"median":-6.080065,"eighty":-2.109349,"marketCap":11456936},{"date":"2024-12-20","current":-0.621353,"twenty":-24.658533,"median":-6.04136,"eighty":-2.101042,"marketCap":10077722},{"date":"2024-12-27","current":-0.728186,"twenty":-24.658533,"median":-6.035031,"eighty":-2.092449,"marketCap":11810453},{"date":"2025-01-03","current":-0.874929,"twenty":-24.658533,"median":-6.01189,"eighty":-2.079851,"marketCap":14190469},{"date":"2025-01-10","current":-0.83195,"twenty":-24.658533,"median":-5.968121,"eighty":-2.073375,"marketCap":13493393},{"date":"2025-01-17","current":-0.801251,"twenty":-24.643618,"median":-5.93531,"eighty":-2.061683,"marketCap":12995482},{"date":"2025-01-24","current":-0.788664,"twenty":-24.633675,"median":-5.894009,"eighty":-2.052312,"marketCap":12791338},{"date":"2025-01-31","current":-0.791427,"twenty":-24.633675,"median":-5.894009,"eighty":-2.04294,"marketCap":12836150},{"date":"2025-02-07","current":-0.997726,"twenty":-24.623732,"median":-5.776129,"eighty":-2.038504,"marketCap":16182114},{"date":"2025-02-14","current":-1.099033,"twenty":-24.608818,"median":-5.658249,"eighty":-2.027617,"marketCap":17825220},{"date":"2025-02-21","current":-0.92282,"twenty":-24.608818,"median":-5.628779,"eighty":-2.021458,"marketCap":14967210},{"date":"2025-02-28","current":-0.775463,"twenty":-24.608818,"median":-5.099654,"eighty":-1.992156,"marketCap":12577236},{"date":"2025-03-07","current":-0.775156,"twenty":-24.608818,"median":-4.778496,"eighty":-1.977341,"marketCap":12572257},{"date":"2025-03-14","current":-0.75643,"twenty":-24.608818,"median":-4.719502,"eighty":-1.959028,"marketCap":12268531},{"date":"2025-03-21","current":-0.722967,"twenty":-24.608818,"median":-4.719502,"eighty":-1.953792,"marketCap":11725808},{"date":"2025-03-28","current":-0.540029,"twenty":-24.608818,"median":-4.704754,"eighty":-1.94913,"marketCap":9487224},{"date":"2025-04-04","current":-0.369934,"twenty":-24.608818,"median":-4.631011,"eighty":-1.92291,"marketCap":6499002},{"date":"2025-04-11","current":-0.367624,"twenty":-24.608818,"median":-4.601514,"eighty":-1.893,"marketCap":6458415},{"date":"2025-04-16","current":-0.355206,"twenty":-24.608818,"median":-4.572017,"eighty":-1.885076,"marketCap":6240260}],"updateTime":1744960905253}}}